Last reviewed · How we verify
NCT03725462: STREAM
Evaluation of Electrophysiological Signal Measured by Smart Textile CE-marked
NA trial testing Cardioskin in Healthy in 30 participants. Completed in 16 April 2019.
2 March 2019
Quick facts
| Lead sponsor | BioSerenity |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 16 October 2017 |
| Primary completion | 2 March 2019 |
| Estimated completion | 16 April 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Cardioskin
- Neuronaute
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
BioSerenity
Who can join
18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim is to evaluate the performance of Cardioskin and Neuronaute, two connected medical devices CE-marked, manufactured by Bioserenity. It's an open monocentric comparative clinical study, where subjects will test the Cardioskin device and/or the Neuronaute device.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03725462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cardioskin
Trials testing the same drug.
- NCT03932227 — EVAluation of the Non Inferiority of Interpretability of Cardiokin Compared to Holter · NA · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other BioSerenity trials
Trials by the same sponsor.
- NCT04875442 — Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions · NA · withdrawn
- NCT03379272 — Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital · NA · withdrawn
- NCT04161716 — Study Evaluating the Ability of a NIRS Module to Detect a Urodynamic Variation in Humans (DETTECH) · NA · completed
- NCT04180410 — Monitoring of Regional Lung Ventilation by Chest Electrical Impedance in the Course of Extubation · NA · unknown
- NCT03805243 — Evaluation of the Signals Electrophysiological Measured by Intelligent Textiles · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03725462 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BioSerenity
- Last refreshed: 9 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03725462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing